Why Viking Therapeutics Inc. (VKTX) Went Down on Monday
We recently published an article titled These 10 Companies Led Monday’s Downturn. In this article, we are going to take a ...
Hosted on MSN5d
Scotiabank Initiates Coverage of Viking Therapeutics (VKTX) with Sector Outperform Recommendation
Fintel reports that on February 13, 2025, Scotiabank initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Sector ...
H.C. Wainwright Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers
We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...
Fintel on MSN10d
Citigroup Initiates Coverage of Viking Therapeutics (VKTX) with Neutral Recommendation
Fintel reports that on February 7, 2025, Citigroup initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...
Nasdaq5d
Viking Therapeutics Becomes Oversold (VKTX)
In trading on Thursday, shares of Viking Therapeutics Inc (Symbol: VKTX) entered into oversold territory, hitting an RSI reading of 29.7, after changing hands as low as $28.81 per share.
Leerink Partnrs Has Negative Outlook of VKTX FY2025 Earnings
Analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Viking Therapeutics in a research note issued to ...
Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock Soaring
Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Viking Therapeutics VKTX has outperformed the market over the past 5 years by 22.07% on an annualized basis producing an ...